The information in this section is intended for visitors outside the United States.
Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014
Gilead’s Sovaldi® Demonstrates Efficacy and Safety Among Chronic Hepatitis C Patients with Advanced Liver Disease
Gilead Announces Phase 2 Results for Two Investigational All-Oral Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C
2013 Annual Review